Siemens Atellica CH Reaction Ring Cuvette Segment-has cuvettes that contain and incubate the sample reaction volumes and present them to each processing step. Siemens Material Number(SMN): 11099326 All lots starting with N15 or 15 are expected to have the defect.
Published November 27, 2024 · Recall initiated: October 21, 2024
Summary
FDA records medical device Class II recall Z-0496-2025, published November 27, 2024 and initiated October 21, 2024. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Ongoing; Reported quantity: 9729 units; Lot: Lot # UDI N1527024 (01)00630414596143(10)N1527024(17)20291002; N1526424 (01)00630414596143(10)N1526424(17)20291001; N1525924 (01)00630414596143(10)N1525924(17)20290924 ; N1525324 (01)00630414596143(10)N1525324(17)20290918 ; N1524224 (01)00630414596143(10)N1524224(17)20290911; N1523724 (01)00630414596143(10)N1523724(17)20290904; N1523024 (01)00630414596143(10)N1523024(17)20290827; N1521824 (01)00630414596143(10)N1521824(17)20290814; N1521424 (01)00630414596143(10)N1521424(17)20290808; N1519324 (01)00630414596143(10)N1519324(17)20290719; N1518924 (01)00630414596143(10)N1518924(17)20290716; N1518224 (01)00630414596143(10)N1518224(17)20290710; N1518324 (01)00630414596143(10)N1518324(17)20290710; N1516224 (01)00630414596143(10)N1516224(17)20290621; N1515624 (01)00630414596143(10)N1515624(17)20290612; N1514924 (01)00630414596143(10)N1514924(17)20290605; N1514124 (01)00630414596143(10)N1514124(17)20290530; N1513324 (01)00630414596143(10)N1513324(17)20290522; N1512824 (01)00630414596143(10)N1512824(17)20290515; N1512424 (01)00630414596143(10)N1512424(17)20290510; N1511224 (01)00630414596143(10)N1511224(17)20290506; N1510724 (01)00630414596143(10)N1510724(17)20290423; N1510124 (01)00630414596143(10)N1510124(17)20290419. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A manufacturing defect causes Atellica CH Reaction Ring Cuvette Segments with lot numbers N15 on the packaging or 15 on the underside of the cuvette segment have a potential for imprecision and erroneously depressed or elevated QC and patient results for seven (7) analytes: Ammonia, Acetaminophen, Alanine Aminotransferase (ALT), Hemoglobin A1c, Creatinine Kinase (CK), Cystatin C, and Salicylate.
What to do
Voluntary: Firm initiated
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Distributor
- US Nationwide and Worldwide distribution: Foreign: Algeria Algeria Argentina Australia Austria Bahrain Bangladesh Belgium Brazil Bulgaria Burkina Faso Canada Chile China Colombia Congo, Republic C®te dIvoire Croatia Cyprus Czech Republic Denmark Ecuador Egypt Estonia Finland France Germany Greece Hong Kong Hungary India Iran, Islamic Republic of Iraq Ireland Israel Italy Japan Jordan Kenya Kuwait Latvia Libya Malaysia Mexico Moldova, Rep. of Morocco Nepal Netherlands Norway Oman Pakistan Paraguay Peru Philippines Poland Portugal Qatar Republic Korea Romania Russian Federation Saudi Arabia Serbia Singapore Slovakia Slovenia South Africa Spain Sweden Switzerland Taiwan, Province of China Thailand Tunisia Turkey Uganda Ukraine United Arab Emirates United Kingdom Great Britain Uruguay Vatikancity Vietnam
- Lot
- Lot # UDI N1527024 (01)00630414596143(10)N1527024(17)20291002; N1526424 (01)00630414596143(10)N1526424(17)20291001; N1525924 (01)00630414596143(10)N1525924(17)20290924 ; N1525324 (01)00630414596143(10)N1525324(17)20290918 ; N1524224 (01)00630414596143(10)N1524224(17)20290911; N1523724 (01)00630414596143(10)N1523724(17)20290904; N1523024 (01)00630414596143(10)N1523024(17)20290827; N1521824 (01)00630414596143(10)N1521824(17)20290814; N1521424 (01)00630414596143(10)N1521424(17)20290808; N1519324 (01)00630414596143(10)N1519324(17)20290719; N1518924 (01)00630414596143(10)N1518924(17)20290716; N1518224 (01)00630414596143(10)N1518224(17)20290710; N1518324 (01)00630414596143(10)N1518324(17)20290710; N1516224 (01)00630414596143(10)N1516224(17)20290621; N1515624 (01)00630414596143(10)N1515624(17)20290612; N1514924 (01)00630414596143(10)N1514924(17)20290605; N1514124 (01)00630414596143(10)N1514124(17)20290530; N1513324 (01)00630414596143(10)N1513324(17)20290522; N1512824 (01)00630414596143(10)N1512824(17)20290515; N1512424 (01)00630414596143(10)N1512424(17)20290510; N1511224 (01)00630414596143(10)N1511224(17)20290506; N1510724 (01)00630414596143(10)N1510724(17)20290423; N1510124 (01)00630414596143(10)N1510124(17)20290419.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAAtellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223;October 7, 2026
- FDABeckman Coulter, Emit 2000 Quinidine Assay REF: OSR4Q229 Contents: R1: 2 x 23 mL;R2 2x13 mLAugust 26, 2026
- FDASyva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL, 1x14mLAugust 26, 2026
- FDASyva Emit tox Serum Tricyclic Antidepressant Calibrator/Controls SMN 10445390 Catalog No. 7C219ULAugust 12, 2026
- FDAAbbott Navitor Transcatheter Aortic Heart Valve, 27 mm, NVTR-27, SterileNovember 27, 2024
- FDAVue PACS Diagnostic Viewer with Vue PACS client 12.1.5 to 12.2.8.454 software Model Number: 1149418 IntendedNovember 27, 2024
Questions about this recall
Was Siemens Atellica CH Reaction Ring Cuvette Segment-has cuvettes that contain and incubate the sample reaction volumes and present them to each processing step. Siemens Material Number(SMN): 11099326 All lots starting with N15 or 15 are expected to have the defect. recalled?
Yes. FDA published recall Z-0496-2025 on November 27, 2024. Reported hazard: A manufacturing defect causes Atellica CH Reaction Ring Cuvette Segments with lot numbers N15 on the packaging or 15 on the underside of the cuvette segment have a potential for imprecision and erroneously depressed or elevated QC and patient results for seven (7) analytes: Ammonia, Acetaminophen, Alanine Aminotransferase (ALT), Hemoglobin A1c, Creatinine Kinase (CK), Cystatin C, and Salicylate.
What should I do if I have this product?
Voluntary: Firm initiated